Pathstone Family Office’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,603	Closed	-$272K	–	1500
2022 Q3	$272K	Buy	+5,603	New	+$272K	﹤0.01%	1243
2020 Q2	–	Sell	-110	Closed	-$1K	–	772
2020 Q1	$1K	Buy	+110	New	+$1K	﹤0.01%	713